Torthaí cuardaigh - Markus Peck‐Radosavljevic

Beachtaigh na torthaí
  1. 1
    Review article: coagulation disorders in chronic liver disease

    Review article: coagulation disorders in chronic liver disease de réir Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Drug Therapy for Advanced-Stage Liver Cancer

    Drug Therapy for Advanced-Stage Liver Cancer de réir Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Thrombocytopenia in Liver Disease

    Thrombocytopenia in Liver Disease de réir Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Thrombocytopenia in chronic liver disease

    Thrombocytopenia in chronic liver disease de réir Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Review article: systemic treatment of hepatocellular carcinoma

    Review article: systemic treatment of hepatocellular carcinoma de réir Matthias Pinter, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Transarterial chemoembolization: Modalities, indication, and patient selection

    Transarterial chemoembolization: Modalities, indication, and patient selection de réir Wolfgang Sieghart, Florian Hucke, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups de réir Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein

    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein de réir Johannes Nimpf, Markus Peck‐Radosavljevic, Wolfgang J. Schneider

    Foilsithe / Cruthaithe 1989
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Cancer and liver cirrhosis: implications on prognosis and management

    Cancer and liver cirrhosis: implications on prognosis and management de réir Matthias Pinter, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    The burden of liver disease in Europe: A review of available epidemiological data

    The burden of liver disease in Europe: A review of available epidemiological data de réir Martin Blachier, Henri Leleu, Markus Peck‐Radosavljevic, Dominique Valla, Françoise Roudot‐Thoraval

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma de réir Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study

    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study de réir Matthias Pinter, Wolfgang Sieghart, Thomas Reiberger, Nataliya Rohr‐Udilova, Arnulf Ferlitsch, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents

    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents de réir Bernhard Angermayr, Manfred Cejna, Franz Koenig, F. Karnel, Franz Hackl, Alfred Gangl, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C de réir A Maieron, Petra Salzl, Markus Peck‐Radosavljevic, Michael Trauner, S Hametner, R Schöfl, Péter Ferenci, Monika Ferlitsch

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis

    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis de réir Simona Bota, Harald Herkner, Ioan Sporea, Petra Salzl, Roxana Şirli, Adriana Maria Neghină, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients

    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients de réir Lana Kosi, Thomas Reiberger, B.A. Payer, Katharina Grabmeier‐Pfistershammer, Robert Straßl, Armin Rieger, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study

    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study de réir Rémy Schwarzer, Danijel Kivaranovic, Rafael Paternostro, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Markus Peck‐Radosavljevic, Arnulf Ferlitsch

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Rapid suppression of hematopoiesis by standard or pegylated interferon-α

    Rapid suppression of hematopoiesis by standard or pegylated interferon-α de réir Markus Peck‐Radosavljevic, Martina Wichlas, Monika Homoncik–Kraml, Anna Kreil, Harald Hofer, Wolfgang Jessner, Alfred Gangl, Peter Ferenci

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection

    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection de réir Thomas Reiberger, Judith H. Aberle, Michael Kundi, Norbert Kohrgruber, Armin Rieger, Alfred Gangl, Heidemarie Holzmann, Markus Peck‐Radosavljevic

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Personalized treatment of patients with very early hepatocellular carcinoma

    Personalized treatment of patients with very early hepatocellular carcinoma de réir Alessandro Vitale, Markus Peck‐Radosavljevic, Edoardo G. Giannini, Éric Vibert, Wolfgang Sieghart, Sven Van Poucke, Timothy M. Pawlik

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: